CT Scans of Fat and Muscle May Predict Liver Failure in Hepatitis B Patients

New research suggests that simple CT scans tracking changes in body fat and muscle could help doctors spot which patients with chronic hepatitis B-related cirrhosis are most likely to develop severe liver complications.

The findings, published recently, offer a potential non-invasive tool for early intervention in a disease that affects millions in India and worldwide.

Fat and Muscle as Early Warning Signs

Researchers found that shifts in body composition—specifically, a decrease in muscle mass and an increase in fatty tissue—measured through routine CT scans, were strongly linked to a higher risk of liver decompensation. This condition includes life-threatening events such as ascites (fluid buildup in the abdomen), variceal bleeding, and hepatic encephalopathy.

Chronic hepatitis B is a leading cause of cirrhosis and liver cancer in India. Many patients are diagnosed late, when complications have already set in.

The study's authors argue that tracking these physical changes could give doctors a crucial head start.

What the Study Found

The research analyzed CT scans of patients with chronic hepatitis B-related cirrhosis over a period of time. It measured both visceral fat—the deep belly fat surrounding organs—and skeletal muscle at the level of the third lumbar vertebra.

Patients who showed a significant loss of muscle (sarcopenia) and an increase in visceral fat were far more likely to develop liver decompensation within the follow-up period. The association held even after adjusting for other known risk factors like liver function scores.

“This gives us a window into the patient's metabolic state, which is closely tied to liver health,” one of the researchers noted, though specific data was not disclosed in the release.

Implications for Clinical Practice

For doctors in India, where hepatitis B remains a major public health challenge, the finding is practical. CT scans are already commonly performed for cirrhosis patients. Using them to also assess body composition adds no extra cost or procedure.

It could help stratify patients: those with concerning muscle and fat changes might be monitored more closely or enrolled in nutritional and exercise interventions earlier.

The study does not prove that reversing these body changes will prevent complications. But it does give clinicians a new way to identify who is at highest risk.

Experts say more research is needed to confirm the findings in larger, more diverse populations, including those in lower-resource settings where hepatitis B is most common.

The next step will be to see if targeted therapies—such as protein supplements or specific exercise regimens—can change the trajectory for these high-risk patients. Until then, the CT scan offers a simple, data-driven warning.